Sickle cell disease is a painful and debilitating genetic condition. It affects over 100,000 people in the U.S. and more than 20 million globally—most are Black or of African origin. Until recently, sickle cell was considered a lifelong disease. Then, in 2019, Victoria Gray became the first patient cured using CRISPR gene-editing technology.
On July 13, Victoria Gray will come to Cold Spring Harbor Laboratory (CSHL) to share her experience. Join CSHL for a free, in-person “Students Talk Science” event, where Gray will discuss sickle cell with a group of high schoolers from the DNA Learning Center’s STARS program. Gray will reflect on her personal journey living with the disease. She’ll also talk about treatment challenges and the newfound hope for patients with genetic disorders. Additionally, scientists and physicians will join the discussion to speak out on the importance of making new scientific knowledge and medical treatments available to all communities.
The event will take place from 1 to 2 p.m. in CSHL’s Grace Auditorium. Registration is free but required. Sign up now to attend.
Written by: Communications Department | publicaffairs@cshl.edu | 516-367-8455